A Study on the Effect of Vitamins A and C to Modulate the Expression of NKG2D Ligands in Hepatic and Colon Cancer Cells

References

• Horowitz A, Stegmann KA, Riley EM. Activation of natural killer cells during microbial infections. Front Immunol. 2011;2:88. doi:https://doi.org/10.3389/fimmu.2011.00088
   PubMed Web of Science ®Google Scholar
• Foley B, Felices M, Cichocki F, Cooley S, Verneris MR, Miller JS. The biology of NK cells and their receptors affects clinical outcomes after hematopoietic cell transplantation (HCT). Immunol Rev. 2014;258(1):45–63. doi:https://doi.org/10.1111/imr.12157
   PubMed Web of Science ®Google Scholar
• Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, Yokoyama WM, Ugolini S. Innate or adaptive immunity? The example of natural killer cells. Science. 2011;331(6013):44–49. doi:https://doi.org/10.1126/science.1198687
   PubMed Web of Science ®Google Scholar
• Cooper MA, Fehniger TA, Turner SC, Chen KS, Ghaheri BA, Ghayur T, Carson WE, Caligiuri MA. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood. 2001;97(10):3146–3151.
   PubMed Web of Science ®Google Scholar
• Vivier E, Nunès JA, Vély F. Natural killer cell signaling pathways. Science. 2004;306(5701):1517–1519. doi:https://doi.org/10.1126/science.1103478
   PubMed Web of Science ®Google Scholar
• Schmiedel D, Mandelboim O. NKG2D ligands-critical targets for cancer immune escape and therapy. Front Immunol. 2018;9:2040. doi:https://doi.org/10.3389/fimmu.2018.02040
   PubMed Web of Science ®Google Scholar
• López-Soto A, Huergo-Zapico L, Acebes-Huerta A, Villa-Alvarez M, Gonzalez S. NKG2D signaling in cancer immunosurveillance. Int J Cancer. 2015;136(8):1741–1750. doi:https://doi.org/10.1002/ijc.28775
   PubMed Web of Science ®Google Scholar
• Bugide S, Janostiak R, Wajapeyee N. Epigenetic mechanisms dictating eradication of cancer by natural killer cells. Trends Cancer. 2018;4(8):553–566. doi:https://doi.org/10.1016/j.trecan.2018.06.004
   PubMed Web of Science ®Google Scholar
• Molinero LL, Fuertes MB, Girart MV, Fainboim L, Rabinovich GA, Costas MA, Zwirner NW. NF-kappa B regulates expression of the MHC class I-related chain A gene in activated T lymphocytes. J Immunol. 2004;173(9):5583–5590.
   PubMed Web of Science ®Google Scholar
• Ogasawara K, Benjamin J, Takaki R, Phillips JH, Lanier KK. Function of NKG2D in natural killer cell–mediated rejection of mouse bone marrow grafts. Nat Immunol. 2005;6(9):938–945.
   PubMed Web of Science ®Google Scholar
• Champsaur M, Lanier LL. Effect of NKG2D ligand expression on host immune responses. Immunol Rev. 2010;235(1):267–285. doi:https://doi.org/10.1111/j.0105-2896.2010.00893.x
   PubMed Web of Science ®Google Scholar
• Baragaño Raneros A, Martín-Palanco V, Fernandez AF, Rodriguez RM, Fraga MF, Lopez-Larrea C, Suarez-Alvarez B. Methylation of NKG2D ligands contributes to immune system evasion in acute myeloid leukemia. Genes Immun. 2015;16(1):71–82. doi:https://doi.org/10.1038/gene.2014.58
   PubMed Web of Science ®Google Scholar
• Bar-El Dadon S, Reifen R. Vitamin A and the epigenome. Crit Rev Food Sci Nutr. 2017;57(11):2404–2411. doi:https://doi.org/10.1080/10408398.2015.1060940
   PubMed Web of Science ®Google Scholar
• Su LJ, Mahabir S, Ellison GL, McGuinn LA, Reid BC. Epigenetic contributions to the relationship between cancer and dietary intake of nutrients, bioactive food components, and environmental toxicants. Front Genet. 2011;2:91. doi:https://doi.org/10.3389/fgene.2011.00091
   PubMedGoogle Scholar
• Gillberg L, Ørskov AD, Liu M, Harsløf LBS, Jones PA, Grønbaek K. Vitamin C - A new player in regulation of the cancer epigenome. Semin Cancer Biol. 2018;51:59–67. doi:https://doi.org/10.1016/j.semcancer.2017.11.001
   PubMed Web of Science ®Google Scholar
• Zappe K, Pointner A, Switzeny OJ, Magnet U, Tomeva E, Heller J, Mare G, Wagner K-H, Knasmueller S, Haslberger AG. Counteraction of oxidative stress by vitamin E affects epigenetic regulation by increasing global methylation and gene expression of MLH1 and DNMT1 dose dependently in caco-2 cells. Oxid Med Cell Longev. 2018;2018:3734250. doi:https://doi.org/10.1155/2018/3734250
   PubMed Web of Science ®Google Scholar
• Camarena V, Wang G. The epigenetic role of vitamin C in health and disease. Cell Mol Life Sci. 2016;73(8):1645–1658. doi:https://doi.org/10.1007/s00018-016-2145-x
   PubMed Web of Science ®Google Scholar
• Wahid B, Ali A, Rafique S, Idrees M. New insights into the epigenetics of hepatocellular carcinoma. Biomed Res Int. 2017;2017:1609575. doi:https://doi.org/10.1155/2017/1609575
   PubMed Web of Science ®Google Scholar
• Chaves GV, Peres WAF, Gonçalves JC, Ramalho A. Vitamin A and retinol-binding protein deficiency among chronic liver disease patients. Nutrition. 2015;31(5):664–668. doi:https://doi.org/10.1016/j.nut.2014.10.016
   PubMed Web of Science ®Google Scholar
• Lan Q-Y, Zhang Y-J, Liao G-C, Zhou R-F, Zhou Z-G, Chen Y-M, Zhu H-L. The association between dietary vitamin A and carotenes and the risk of primary liver cancer: a case-control study. Nutrients. 2016;8(10):624. doi:https://doi.org/10.3390/nu8100
   Web of Science ®Google Scholar
• Lv H, Wang C, Fang T. Vitamin C preferentially kills cancer stem cells in hepatocellular carcinoma via SVCT-2. npj Precis Oncol. 2018;2(1):1. doi:https://doi.org/10.1038/s41698-017-0044-8
   PubMed Web of Science ®Google Scholar
• Chen Q, Espey MG, Sun AY, Pooput C, Kirk KL, Krishna MC, Khosh DB, Drisko J, Levine M. Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc Natl Acad Sci USA. 2008;105(32):11105–11109. doi:https://doi.org/10.1073/pnas.0804226105
   PubMed Web of Science ®Google Scholar
• Cameron E, Pauling L. Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer. Proc Natl Acad Sci USA. 1978;75(9):4538–4542.
   PubMed Web of Science ®Google Scholar
• Zhang W, Shu X-O, Li H, Yang G, Cai H, Ji B-T, Gao J, Gao Y-T, Zheng W, Xiang Y-B, et al. Vitamin intake and liver cancer risk: a report from two cohort studies in China. J Natl Cancer Inst. 2012;104(15):1173–1181. doi:https://doi.org/10.1093/jnci/djs277
   PubMedGoogle Scholar
• Bugide S, Green MR, Wajapeyee N. Inhibition of Enhancer of zeste homolog 2 (EZH2) induces natural killer cell-mediated eradication of hepatocellular carcinoma cells. Proc Natl Acad Sci USA. 2018;115(15):E3509–E3518. doi:https://doi.org/10.1073/pnas.1802691115
   PubMed Web of Science ®Google Scholar
• Ghadially H, Brown L, Lloyd C, Lewis L, Lewis A, Dillon J, Sainson R, Jovanovic J, Tigue NJ, Bannister D, et al. MHC class I chain-related protein A and B (MICA and MICB) are predominantly expressed intracellularly in tumour and normal tissue. Br J Cancer. 2017;116(9):1208–1217. doi:https://doi.org/10.1038/bjc.2017.79
   PubMed Web of Science ®Google Scholar
• Watson NFS, Spendlove I, Madjd Z, McGilvray R, Green AR, Ellis IO, Scholefield JH, Durrant LG. Expression of the stress-related MHC class I chain-related protein MICA is an indicator of good prognosis in colorectal cancer patients. Int J Cancer. 2006;118(6):1445–1452. doi:https://doi.org/10.1002/ijc.21510
   PubMed Web of Science ®Google Scholar
• Zhang W, Xu J. DNA methyltransferases and their roles in tumorigenesis. Biomark Res. 2017;5:1. doi:https://doi.org/10.1186/s40364-017-0081-z
   PubMed Web of Science ®Google Scholar
• Fang Q-L, Yin Y-R, Xie C-R, Zhang S, Zhao W-X, Pan C, Wang X-M, Yin Z-Y. Mechanistic and biological significance of DNA methyltransferase 1 upregulated by growth factors in human hepatocellular carcinoma. Int J Oncol. 2015;46(2):782–790. doi:https://doi.org/10.3892/ijo.2014.2776
   PubMed Web of Science ®Google Scholar
• Nishida N, Kudo M. Alteration of epigenetic profile in human hepatocellular carcinoma and its clinical implications. Liver Cancer. 2014;3(3–4):417–427. doi:https://doi.org/10.1159/000343860
   PubMed Web of Science ®Google Scholar
• Mizuno S, Chijiwa T, Okamura T, Akashi K, Fukumaki Y, Niho Y, Sasaki H. Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia. Blood. 2001;97(5):1172–1179.
   PubMed Web of Science ®Google Scholar
• Foran E, Garrity-Park MM, Mureau C, Newell J, Smyrk TC, Limburg PJ, Egan LJ. Upregulation of DNA methyltransferase-mediated gene silencing, anchorage-independent growth, and migration of colon cancer cells by interleukin-6. Mol Cancer Res. 2010;8(4):471–481. doi:https://doi.org/10.1158/1541-7786.MCR-09-0496
   PubMed Web of Science ®Google Scholar
• Rhee I, Bachman KE, Park BH, Jair K-W, Yen R-WC, Schuebel KE, Cui H, Feinberg AP, Lengauer C, Kinzler KW, et al. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature. 2002;416(6880):552–556. doi:https://doi.org/10.1038/416552a
   PubMed Web of Science ®Google Scholar
• Kohli RM, Zhang Y. TET enzymes, TDG and the dynamics of DNA demethylation. Nature. 2013;502(7472):472–479. doi:https://doi.org/10.1038/nature12750
   PubMed Web of Science ®Google Scholar
• Lin G, Sun W, Yang Z, Guo J, Liu H, Liang J. Hypoxia induces the expression of TET enzymes in HepG2 cells. Oncol Lett. 2017;14(6):6457–6462. doi:https://doi.org/10.3892/ol.2017.7063
   PubMed Web of Science ®Google Scholar
• Yang L, Yu S-J, Hong Q, Yang Y, Shao Z-M. Reduced expression of TET1, TET2, TET3 and TDG mRNAs are associated with poor prognosis of patients with early breast cancer. Guan X-Y, ed. PLoS One. 2015;10(7):e0133896. doi:https://doi.org/10.1371/journal.pone.0133896
   PubMed Web of Science ®Google Scholar
• Yang H, Liu Y, Bai F, Zhang J-Y, Ma S-H, Liu J, Xu Z-D, Zhu H-G, Ling Z-Q, Ye D, et al. Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation. Oncogene. 2013;32(5):663–669. doi:https://doi.org/10.1038/onc.2012.67
   PubMed Web of Science ®Google Scholar
• Kai M, Niinuma T, Kitajima H, Yamamoto E, Harada T, Aoki H, Maruyama R, Toyota M, Sasaki Y, Sugai T, et al. TET1 depletion induces aberrant CpG methylation in colorectal cancer cells. PLoS One. 2016;11(12):e0168281. doi:https://doi.org/10.1371/journal.pone.0168281
   PubMed Web of Science ®Google Scholar
• Sánchez-Abarca LI, Gutierrez-Cosio S, Santamaría C, Caballero-Velazquez T, Blanco B, Herrero-Sánchez C, García JL, Carrancio S, Hernández-Campo P, González FJ, et al. Immunomodulatory effect of 5-azacytidine (5-azaC): potential role in the transplantation setting. Blood. 2010;115(1):107–121. doi:https://doi.org/10.1182/blood-2009-03-210393
   PubMed Web of Science ®Google Scholar
• Gailhouste L, Liew LC, Yasukawa K, Hatada I, Tanaka Y, Nakagama H, Ochiya T. Differentiation therapy by epigenetic reconditioning exerts antitumor effects on liver cancer cells. Mol Ther. 2018;26(7):1840–1854. doi:https://doi.org/10.1016/j.ymthe.2018.04.018
   Google Scholar
• Schneider-Stock R, Diab-Assef M, Rohrbeck A, Foltzer-Jourdainne C, Boltze C, Hartig R, Schönfeld P, Roessner A, Gali-Muhtasib H. 5-Aza-cytidine is a potent inhibitor of DNA methyltransferase 3a and induces apoptosis in HCT-116 colon cancer cells via Gadd45- and p53-dependent mechanisms. J Pharmacol Exp Ther. 2005;312(2):525–536. doi:https://doi.org/10.1124/jpet.104.074195
   PubMed Web of Science ®Google Scholar
• Módis K, Coletta C, Asimakopoulou A, Szczesny B, Chao C, Papapetropoulos A, Hellmich MR, Szabo C. Effect of S-adenosyl-L-methionine (SAM), an allosteric activator of cystathionine-β-synthase (CBS) on colorectal cancer cell proliferation and bioenergetics in vitro. Nitric Oxide. 2014;41:146–156. doi:https://doi.org/10.1016/J.NIOX.2014.03.001
   PubMed Web of Science ®Google Scholar
• Hussain Z, Khan MI, Shahid M, Almajhdi FN. S-adenosylmethionine, a methyl donor, up regulates tissue inhibitor of metalloproteinase-2 in colorectal cancer. Genet Mol Res. 2013;12(2):1106–1118. doi:https://doi.org/10.4238/2013.April.10.6
   PubMed Web of Science ®Google Scholar
• Shrubsole MJ, Wagner C, Zhu X, Hou L, Loukachevitch LV, Ness RM, Zheng W. Associations between S-adenosylmethionine, S-adenosylhomocysteine, and colorectal adenoma risk are modified by sex. Am J Cancer Res. 2015;5(1):458–465.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:https://doi.org/10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Nagai H, Kim YH. Cancer prevention from the perspective of global cancer burden patterns. J Thorac Dis. 2017;9(3):448–451. doi:https://doi.org/10.21037/jtd.2017.02.75
   PubMed Web of Science ®Google Scholar
• Jasiulionis MG. Abnormal epigenetic regulation of immune system during aging. Front Immunol. 2018;9:197. doi:https://doi.org/10.3389/fimmu.2018.00197
   PubMed Web of Science ®Google Scholar
• Zhang Q, Cao X. Epigenetic regulation of the innate immune response to infection. Nat Rev Immunol. 2019;19(7):417–432. doi:https://doi.org/10.1038/s41577-019-0151-6
   PubMed Web of Science ®Google Scholar
• Anderson OS, Sant KE, Dolinoy DC. Nutrition and epigenetics: an interplay of dietary methyl donors, one-carbon metabolism and DNA methylation. J Nutr Biochem. 2012;23(8):853–859. doi:https://doi.org/10.1016/j.jnutbio.2012.03.003
   PubMed Web of Science ®Google Scholar
• Blaschke K, Ebata KT, Karimi MM, Zepeda-Martínez JA, Goyal P, Mahapatra S, Tam A, Laird DJ, Hirst M, Rao A, et al. Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells. Nature. 2013;500(7461):222–226. doi:https://doi.org/10.1038/nature12362
   PubMed Web of Science ®Google Scholar
• Melo F. d, Oliveira JS, Sartorelli VOB, Montor WR. Cancer chemoprevention: classic and epigenetic mechanisms inhibiting tumorigenesis. What have we learned so far? Front Oncol. 2018;8:644. doi:https://doi.org/10.3389/fonc.2018.00644
   PubMed Web of Science ®Google Scholar